Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Sep 2011 - Clin. Cancer Res.; 17(17):1078-0432 [PMID:21771874]
[Lesterhuis WJ] [de Vries IJ] [Schreibelt G] [Lambeck AJ] [Aarntzen EH] [Jacobs JF] [Scharenborg NM] [van de Rakt MW] [de Boer AJ] [Croockewit S] [van Rossum MM] [Mus R] [Oyen WJ] [Boerman OC] [Lucas S] [Adema GJ] [Punt CJ] [Figdor CG]

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Apr 2009 - Clin. Cancer Res.; 15(7):1078-0432 [PMID:19318472]
[Verdijk P] [Aarntzen EH] [Lesterhuis WJ] [Boullart AC] [Kok E] [van Rossum MM] [Strijk S] [Eijckeler F] [Bonenkamp JJ] [Jacobs JF] [Blokx W] [Vankrieken JH] [Joosten I] [Boerman OC] [Oyen WJ] [Adema G] [Punt CJ] [Figdor CG] [de Vries IJ]